Acorda Therapeutics
ACOR
#10419
Rank
โ‚ฌ0.74 M
Marketcap
0,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -9,87ย โ‚ฌ

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -8,87ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -80,01ย โ‚ฌ an increase over its 2021 EPS that were of -181,06ย โ‚ฌ.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,87ย โ‚ฌ-87.66%
2022-80,01ย โ‚ฌ-55.81%
2021-181,06ย โ‚ฌ-16.13%
2020-215,89ย โ‚ฌ-65.51%
2019-625,90ย โ‚ฌ-898.61%
201878,37ย โ‚ฌ-114.88%
2017-526,84ย โ‚ฌ536.84%
2016-82,73ย โ‚ฌ-392.31%
201528,30ย โ‚ฌ-39.53%
201446,81ย โ‚ฌ4.88%
201344,63ย โ‚ฌ-89.54%
2012426,70ย โ‚ฌ409.09%
201183,82ย โ‚ฌ-333.33%
2010-35,92ย โ‚ฌ-85.14%
2009-241,65ย โ‚ฌ1.37%
2008-238,39ย โ‚ฌ51.03%
2007-157,84ย โ‚ฌ-68.27%
2006-497,45ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,90ย โ‚ฌ-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
0,71ย โ‚ฌ-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,72ย โ‚ฌ-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-7,10ย โ‚ฌ-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA